Cic edizioni internazionali
Functional Neurology

Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms.

Original Article, 227 - 232
Tag this article
Full text HTML Full text PDF
First-ever stroke patients (n=20) with a DSM-IV diagnosis of major depressive disorder (MDD) were included in an open-label study and received a single oral dose (50-100 mg) of the selective serotonin reuptake inhibitor sertraline. At days 0, 7, 14, 28, 42, and 56, a psychometric test battery comprising the Hamilton rating scales for depression and anxiety, the Mini Mental State Examination and the Barthel Index was administered. At the endpoint, 9 (45%) of the subjects were no longer depressed, 4 (20%) presented minor depression, and 7 (35%) still suffered from MDD. Considering the whole group of treated patients, depression and anxiety symptoms were found to decrease continuously and cognitive and functional performances to improve continuously during the treatment. Furthermore, differences between the values recorded by the treatment responders and non responders at the end of follow up were highly significant (p<0.02 for all comparisons). This report suggests that sertraline treatment of post-stroke MDD could be effective and well tolerated. However, non responders to the treatment are at risk of poor outcome. Double blind studies with a greater number of patients are necessary to confirm these preliminary results.

Vol. XXXIV (No. 1) 2019 January - March

  1. Robots for stroke rehabilitation: not all that glitters is gold
    Morone G.
  2. Visual-spatial training in patients with sub-acute stroke without neglect: a randomized, single-blind controlled trial
    Tramontano M., Dell'Uomo D., Cinnera A.M., Luciani C., Di Lorenzo C., Marcotulli M., Vona F., Mercuro A., Abbruzzese S.
  3. Hearing and cognitive impairment: a functional evaluation of associative brain areas in patients affected by Alzheimer’s disease
    Chiaravalloti A., Fuccillo E., Martorana A., Ricci M., Giacomini P.G., Schillaci O., Di Girolamo S.
  4. The role of Personal KinetiGraph™ fluctuator score in quantifying the progression of motor fluctuations in Parkinson’s disease
    Tan E.E., Hogg E.J., Tagliati M.
  5. Evaluation of the psychometric properties of the Barthel Index in an Italian ischemic stroke population in the acute phase: a cross-sectional study
    Galeoto G., Formica M.C., Mercuri N.B., Santilli V., Berardi A. C., Castiglia S.F., Mollica R., Servadio A.
  6. Augmentative and alternative communication improves quality of life in the early stages of amyotrophic lateral sclerosis
    Maresca G., Pranio F., Naro A., De Luca R., Maggio M.G., Scarcella I., De Domenico C., Bramanti P., Conti Nibali V., Portaro S., Calabrò R.S.
  7. Effectiveness of intensive neurorehabilitation in obese subacute stroke patients
    Ciancarelli I., Tonin P., Garo M.L., Tozzi Ciancarelli M.G.
  8. A novel neurocognitive rehabilitation tool in the recovery of hemiplegic hand grip after stroke: a case report
    Paolucci T., Capobianco S.V., Vinciguerra S.M., Cilli M., Villani C., Saraceni V.M.
Last Viewed articles: la lista degli ultimi x visitati.
  1. Sertraline treatment of post-stroke major depression: an open study in patients with moderate to severe symptoms.
    Spalletta G., Caltagirone C.